Big Opportunity For Indian Drugmakers as 24 Mega-Seller Drugs Set to Lose Patent by 2030: Govt Study – News18
From global mega-seller arthritis and cancer drugs, Humira and Keytruda, to popular asthma inhaler Symbicort, 24 major blockbuster drugs are...